Charles Freeman: Method of selecting an intraocular lens material. Patrick M Ryan, R&D Counsel Q 148, April 19, 2001: US20010000351-A1

A method of selecting an intraocular lens material for reducing the risk of posterior capsule opacification is disclosed. The method comprises determining the tack of the material.

Bahram Asgharian: Ophthalmic compositions containing galactomannan polymers and borate. Michael C Mayo R&D Counsel, Alcon Laboratories, May 3, 2007: US20070098677-A1

The present invention is directed to ophthalmic compositions containing a gelling amount of a combination of galactomannan polysaccharides and borates. The compositions gel or partially gel upon administration to the eye. The present invention also discloses methods of topical ophthalmic administrat ...

Ronnie C Barker, John C Lang, Ralph P Stone: Treatment of amd with combination of ingredients. Alcon Research, Theresa J Schultz R&D Counsel, March 15, 2007: US20070059381-A1

The present invention is directed to methods for enhancing current treatment regimens for age-related macular degeneration (AMD). The methods of the invention include intraocular delivery of AMD compositions along with antioxidant compositions. Alternatively, the methods of the invention include a d ...

Michael A Kapin, David P Bingaman, Daniel A Gamache, Gustav Graff, John M Yanni: Method of treating angiogenesis-related disorders. Alcon Universal, R&D Counsel, March 28, 2002: US20020037929-A1

The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat angiogenesis-related disorders, including ophthalmic angiogenesis-related disorders such as diabetic retinopathy and exudative macular degeneration, is disclosed.

Pete Delgado, Raymond E Conrow, W Dennis Dean: 1-alkyl-3-aminoindazoles. R & D Counsel, Alcon Research, March 9, 2006: US20060052613-A1

Methods of making 1-alkylindazoles are described. The methods involve reacting a 2-alkylaminobenzonitrile with a nitrosating agent followed by reduction-cyclization of the resulting nitrosamine to form a 1-alkyl-3-aminoindazole. The 1-alkyl-3-aminoindazole can be deaminated to form a 1-alkylindazole ...